Global Attenuated Vaccine Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Attenuated Vaccine market size was estimated at USD 5486.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Attenuated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Attenuated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Attenuated Vaccine market.
Global Attenuated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck & Co.
GlaxoSmithKline plc
Pfizer Inc
Sanofi
Astellas Pharma
Johnson & Johnson
CSL Limited
Serum Institute of India Pvt. Ltd.
Biken
Green Cross Corporation
Shanghai Rongsheng Biotech
Changchun BCHT Biotechnology Co.,Ltd
Market Segmentation (by Type)
Bacterial Vaccine
Viral Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Attenuated Vaccine Market
Overview of the regional outlook of the Attenuated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Attenuated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Attenuated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Attenuated Vaccine market size was estimated at USD 5486.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Attenuated Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Attenuated Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Attenuated Vaccine market.
Global Attenuated Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck & Co.
GlaxoSmithKline plc
Pfizer Inc
Sanofi
Astellas Pharma
Johnson & Johnson
CSL Limited
Serum Institute of India Pvt. Ltd.
Biken
Green Cross Corporation
Shanghai Rongsheng Biotech
Changchun BCHT Biotechnology Co.,Ltd
Market Segmentation (by Type)
Bacterial Vaccine
Viral Vaccine
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Attenuated Vaccine Market
Overview of the regional outlook of the Attenuated Vaccine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Attenuated Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Attenuated Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Attenuated Vaccine
1.2 Key Market Segments
1.2.1 Attenuated Vaccine Segment by Type
1.2.2 Attenuated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ATTENUATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Attenuated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Attenuated Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ATTENUATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Attenuated Vaccine Product Life Cycle
3.3 Global Attenuated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Attenuated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Attenuated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Attenuated Vaccine Market Competitive Situation and Trends
3.8.1 Attenuated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Attenuated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ATTENUATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Attenuated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ATTENUATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Attenuated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Attenuated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 ATTENUATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Attenuated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Attenuated Vaccine Market Size by Type (2020-2025)
6.4 Global Attenuated Vaccine Price by Type (2020-2025)
7 ATTENUATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Attenuated Vaccine Market Sales by Application (2020-2025)
7.3 Global Attenuated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Attenuated Vaccine Sales Growth Rate by Application (2020-2025)
8 ATTENUATED VACCINE MARKET SALES BY REGION
8.1 Global Attenuated Vaccine Sales by Region
8.1.1 Global Attenuated Vaccine Sales by Region
8.1.2 Global Attenuated Vaccine Sales Market Share by Region
8.2 Global Attenuated Vaccine Market Size by Region
8.2.1 Global Attenuated Vaccine Market Size by Region
8.2.2 Global Attenuated Vaccine Market Size by Region
8.3 North America
8.3.1 North America Attenuated Vaccine Sales by Country
8.3.2 North America Attenuated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Attenuated Vaccine Sales by Country
8.4.2 Europe Attenuated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Attenuated Vaccine Sales by Region
8.5.2 Asia Pacific Attenuated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Attenuated Vaccine Sales by Country
8.6.2 South America Attenuated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Attenuated Vaccine Sales by Region
8.7.2 Middle East and Africa Attenuated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ATTENUATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Attenuated Vaccine by Region(2020-2025)
9.2 Global Attenuated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Attenuated Vaccine Production
9.4.1 North America Attenuated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Attenuated Vaccine Production
9.5.1 Europe Attenuated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Attenuated Vaccine Production (2020-2025)
9.6.1 Japan Attenuated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Attenuated Vaccine Production (2020-2025)
9.7.1 China Attenuated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck and Co.
10.1.1 Merck and Co. Basic Information
10.1.2 Merck and Co. Attenuated Vaccine Product Overview
10.1.3 Merck and Co. Attenuated Vaccine Product Market Performance
10.1.4 Merck and Co. Business Overview
10.1.5 Merck and Co. SWOT Analysis
10.1.6 Merck and Co. Recent Developments
10.2 GlaxoSmithKline plc
10.2.1 GlaxoSmithKline plc Basic Information
10.2.2 GlaxoSmithKline plc Attenuated Vaccine Product Overview
10.2.3 GlaxoSmithKline plc Attenuated Vaccine Product Market Performance
10.2.4 GlaxoSmithKline plc Business Overview
10.2.5 GlaxoSmithKline plc SWOT Analysis
10.2.6 GlaxoSmithKline plc Recent Developments
10.3 Pfizer Inc
10.3.1 Pfizer Inc Basic Information
10.3.2 Pfizer Inc Attenuated Vaccine Product Overview
10.3.3 Pfizer Inc Attenuated Vaccine Product Market Performance
10.3.4 Pfizer Inc Business Overview
10.3.5 Pfizer Inc SWOT Analysis
10.3.6 Pfizer Inc Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Attenuated Vaccine Product Overview
10.4.3 Sanofi Attenuated Vaccine Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Astellas Pharma
10.5.1 Astellas Pharma Basic Information
10.5.2 Astellas Pharma Attenuated Vaccine Product Overview
10.5.3 Astellas Pharma Attenuated Vaccine Product Market Performance
10.5.4 Astellas Pharma Business Overview
10.5.5 Astellas Pharma Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Attenuated Vaccine Product Overview
10.6.3 Johnson and Johnson Attenuated Vaccine Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 CSL Limited
10.7.1 CSL Limited Basic Information
10.7.2 CSL Limited Attenuated Vaccine Product Overview
10.7.3 CSL Limited Attenuated Vaccine Product Market Performance
10.7.4 CSL Limited Business Overview
10.7.5 CSL Limited Recent Developments
10.8 Serum Institute of India Pvt. Ltd.
10.8.1 Serum Institute of India Pvt. Ltd. Basic Information
10.8.2 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Overview
10.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Market Performance
10.8.4 Serum Institute of India Pvt. Ltd. Business Overview
10.8.5 Serum Institute of India Pvt. Ltd. Recent Developments
10.9 Biken
10.9.1 Biken Basic Information
10.9.2 Biken Attenuated Vaccine Product Overview
10.9.3 Biken Attenuated Vaccine Product Market Performance
10.9.4 Biken Business Overview
10.9.5 Biken Recent Developments
10.10 Green Cross Corporation
10.10.1 Green Cross Corporation Basic Information
10.10.2 Green Cross Corporation Attenuated Vaccine Product Overview
10.10.3 Green Cross Corporation Attenuated Vaccine Product Market Performance
10.10.4 Green Cross Corporation Business Overview
10.10.5 Green Cross Corporation Recent Developments
10.11 Shanghai Rongsheng Biotech
10.11.1 Shanghai Rongsheng Biotech Basic Information
10.11.2 Shanghai Rongsheng Biotech Attenuated Vaccine Product Overview
10.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Product Market Performance
10.11.4 Shanghai Rongsheng Biotech Business Overview
10.11.5 Shanghai Rongsheng Biotech Recent Developments
10.12 Changchun BCHT Biotechnology Co.,Ltd
10.12.1 Changchun BCHT Biotechnology Co.,Ltd Basic Information
10.12.2 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Overview
10.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Market Performance
10.12.4 Changchun BCHT Biotechnology Co.,Ltd Business Overview
10.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Developments
11 ATTENUATED VACCINE MARKET FORECAST BY REGION
11.1 Global Attenuated Vaccine Market Size Forecast
11.2 Global Attenuated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Attenuated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Attenuated Vaccine Market Size Forecast by Region
11.2.4 South America Attenuated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Attenuated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Attenuated Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Attenuated Vaccine by Type (2026-2035)
12.1.2 Global Attenuated Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Attenuated Vaccine by Type (2026-2035)
12.2 Global Attenuated Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Attenuated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Attenuated Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Attenuated Vaccine
1.2 Key Market Segments
1.2.1 Attenuated Vaccine Segment by Type
1.2.2 Attenuated Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ATTENUATED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Attenuated Vaccine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Attenuated Vaccine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ATTENUATED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Attenuated Vaccine Product Life Cycle
3.3 Global Attenuated Vaccine Sales by Manufacturers (2020-2025)
3.4 Global Attenuated Vaccine Revenue Market Share by Manufacturers (2020-2025)
3.5 Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Attenuated Vaccine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Attenuated Vaccine Market Competitive Situation and Trends
3.8.1 Attenuated Vaccine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Attenuated Vaccine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ATTENUATED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Attenuated Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ATTENUATED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Attenuated Vaccine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Attenuated Vaccine Market
5.7 ESG Ratings of Leading Companies
6 ATTENUATED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Attenuated Vaccine Sales Market Share by Type (2020-2025)
6.3 Global Attenuated Vaccine Market Size by Type (2020-2025)
6.4 Global Attenuated Vaccine Price by Type (2020-2025)
7 ATTENUATED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Attenuated Vaccine Market Sales by Application (2020-2025)
7.3 Global Attenuated Vaccine Market Size (M USD) by Application (2020-2025)
7.4 Global Attenuated Vaccine Sales Growth Rate by Application (2020-2025)
8 ATTENUATED VACCINE MARKET SALES BY REGION
8.1 Global Attenuated Vaccine Sales by Region
8.1.1 Global Attenuated Vaccine Sales by Region
8.1.2 Global Attenuated Vaccine Sales Market Share by Region
8.2 Global Attenuated Vaccine Market Size by Region
8.2.1 Global Attenuated Vaccine Market Size by Region
8.2.2 Global Attenuated Vaccine Market Size by Region
8.3 North America
8.3.1 North America Attenuated Vaccine Sales by Country
8.3.2 North America Attenuated Vaccine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Attenuated Vaccine Sales by Country
8.4.2 Europe Attenuated Vaccine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Attenuated Vaccine Sales by Region
8.5.2 Asia Pacific Attenuated Vaccine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Attenuated Vaccine Sales by Country
8.6.2 South America Attenuated Vaccine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Attenuated Vaccine Sales by Region
8.7.2 Middle East and Africa Attenuated Vaccine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ATTENUATED VACCINE MARKET PRODUCTION BY REGION
9.1 Global Production of Attenuated Vaccine by Region(2020-2025)
9.2 Global Attenuated Vaccine Revenue Market Share by Region (2020-2025)
9.3 Global Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Attenuated Vaccine Production
9.4.1 North America Attenuated Vaccine Production Growth Rate (2020-2025)
9.4.2 North America Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Attenuated Vaccine Production
9.5.1 Europe Attenuated Vaccine Production Growth Rate (2020-2025)
9.5.2 Europe Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Attenuated Vaccine Production (2020-2025)
9.6.1 Japan Attenuated Vaccine Production Growth Rate (2020-2025)
9.6.2 Japan Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Attenuated Vaccine Production (2020-2025)
9.7.1 China Attenuated Vaccine Production Growth Rate (2020-2025)
9.7.2 China Attenuated Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck and Co.
10.1.1 Merck and Co. Basic Information
10.1.2 Merck and Co. Attenuated Vaccine Product Overview
10.1.3 Merck and Co. Attenuated Vaccine Product Market Performance
10.1.4 Merck and Co. Business Overview
10.1.5 Merck and Co. SWOT Analysis
10.1.6 Merck and Co. Recent Developments
10.2 GlaxoSmithKline plc
10.2.1 GlaxoSmithKline plc Basic Information
10.2.2 GlaxoSmithKline plc Attenuated Vaccine Product Overview
10.2.3 GlaxoSmithKline plc Attenuated Vaccine Product Market Performance
10.2.4 GlaxoSmithKline plc Business Overview
10.2.5 GlaxoSmithKline plc SWOT Analysis
10.2.6 GlaxoSmithKline plc Recent Developments
10.3 Pfizer Inc
10.3.1 Pfizer Inc Basic Information
10.3.2 Pfizer Inc Attenuated Vaccine Product Overview
10.3.3 Pfizer Inc Attenuated Vaccine Product Market Performance
10.3.4 Pfizer Inc Business Overview
10.3.5 Pfizer Inc SWOT Analysis
10.3.6 Pfizer Inc Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Attenuated Vaccine Product Overview
10.4.3 Sanofi Attenuated Vaccine Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Astellas Pharma
10.5.1 Astellas Pharma Basic Information
10.5.2 Astellas Pharma Attenuated Vaccine Product Overview
10.5.3 Astellas Pharma Attenuated Vaccine Product Market Performance
10.5.4 Astellas Pharma Business Overview
10.5.5 Astellas Pharma Recent Developments
10.6 Johnson and Johnson
10.6.1 Johnson and Johnson Basic Information
10.6.2 Johnson and Johnson Attenuated Vaccine Product Overview
10.6.3 Johnson and Johnson Attenuated Vaccine Product Market Performance
10.6.4 Johnson and Johnson Business Overview
10.6.5 Johnson and Johnson Recent Developments
10.7 CSL Limited
10.7.1 CSL Limited Basic Information
10.7.2 CSL Limited Attenuated Vaccine Product Overview
10.7.3 CSL Limited Attenuated Vaccine Product Market Performance
10.7.4 CSL Limited Business Overview
10.7.5 CSL Limited Recent Developments
10.8 Serum Institute of India Pvt. Ltd.
10.8.1 Serum Institute of India Pvt. Ltd. Basic Information
10.8.2 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Overview
10.8.3 Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Market Performance
10.8.4 Serum Institute of India Pvt. Ltd. Business Overview
10.8.5 Serum Institute of India Pvt. Ltd. Recent Developments
10.9 Biken
10.9.1 Biken Basic Information
10.9.2 Biken Attenuated Vaccine Product Overview
10.9.3 Biken Attenuated Vaccine Product Market Performance
10.9.4 Biken Business Overview
10.9.5 Biken Recent Developments
10.10 Green Cross Corporation
10.10.1 Green Cross Corporation Basic Information
10.10.2 Green Cross Corporation Attenuated Vaccine Product Overview
10.10.3 Green Cross Corporation Attenuated Vaccine Product Market Performance
10.10.4 Green Cross Corporation Business Overview
10.10.5 Green Cross Corporation Recent Developments
10.11 Shanghai Rongsheng Biotech
10.11.1 Shanghai Rongsheng Biotech Basic Information
10.11.2 Shanghai Rongsheng Biotech Attenuated Vaccine Product Overview
10.11.3 Shanghai Rongsheng Biotech Attenuated Vaccine Product Market Performance
10.11.4 Shanghai Rongsheng Biotech Business Overview
10.11.5 Shanghai Rongsheng Biotech Recent Developments
10.12 Changchun BCHT Biotechnology Co.,Ltd
10.12.1 Changchun BCHT Biotechnology Co.,Ltd Basic Information
10.12.2 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Overview
10.12.3 Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Market Performance
10.12.4 Changchun BCHT Biotechnology Co.,Ltd Business Overview
10.12.5 Changchun BCHT Biotechnology Co.,Ltd Recent Developments
11 ATTENUATED VACCINE MARKET FORECAST BY REGION
11.1 Global Attenuated Vaccine Market Size Forecast
11.2 Global Attenuated Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Attenuated Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Attenuated Vaccine Market Size Forecast by Region
11.2.4 South America Attenuated Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Attenuated Vaccine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Attenuated Vaccine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Attenuated Vaccine by Type (2026-2035)
12.1.2 Global Attenuated Vaccine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Attenuated Vaccine by Type (2026-2035)
12.2 Global Attenuated Vaccine Market Forecast by Application (2026-2035)
12.2.1 Global Attenuated Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Attenuated Vaccine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Attenuated Vaccine Market Size by Type (M USD)
Table 4. Global Attenuated Vaccine Market Size by Application
Table 5. Attenuated Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Attenuated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Attenuated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Attenuated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Attenuated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attenuated Vaccine as of 2025)
Table 11. Global Market Attenuated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Attenuated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Attenuated Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Attenuated Vaccine Sales by Type (K MT)
Table 27. Global Attenuated Vaccine Market Size by Type (M USD)
Table 28. Global Attenuated Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Attenuated Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Attenuated Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Attenuated Vaccine Market Share by Type (2020-2025)
Table 32. Global Attenuated Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Attenuated Vaccine Sales (K MT) by Application
Table 34. Global Attenuated Vaccine Market Size by Application
Table 35. Global Attenuated Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Attenuated Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Attenuated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Attenuated Vaccine Market Share by Application (2020-2025)
Table 39. Global Attenuated Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Attenuated Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Attenuated Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Attenuated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Attenuated Vaccine Market Size by Region (2020-2025)
Table 44. North America Attenuated Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Attenuated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Attenuated Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Attenuated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Attenuated Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Attenuated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Attenuated Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Attenuated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Attenuated Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Attenuated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Attenuated Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Attenuated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Attenuated Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck and Co. Basic Information
Table 63. Merck and Co. Attenuated Vaccine Product Overview
Table 64. Merck and Co. Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck and Co. Business Overview
Table 66. Merck and Co. SWOT Analysis
Table 67. Merck and Co. Recent Developments
Table 68. GlaxoSmithKline plc Basic Information
Table 69. GlaxoSmithKline plc Attenuated Vaccine Product Overview
Table 70. GlaxoSmithKline plc Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline plc Business Overview
Table 72. GlaxoSmithKline plc SWOT Analysis
Table 73. GlaxoSmithKline plc Recent Developments
Table 74. Pfizer Inc Basic Information
Table 75. Pfizer Inc Attenuated Vaccine Product Overview
Table 76. Pfizer Inc Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Inc Business Overview
Table 78. Pfizer Inc SWOT Analysis
Table 79. Pfizer Inc Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Attenuated Vaccine Product Overview
Table 82. Sanofi Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. Astellas Pharma Basic Information
Table 86. Astellas Pharma Attenuated Vaccine Product Overview
Table 87. Astellas Pharma Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Astellas Pharma Business Overview
Table 89. Astellas Pharma Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Attenuated Vaccine Product Overview
Table 92. Johnson and Johnson Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. CSL Limited Basic Information
Table 96. CSL Limited Attenuated Vaccine Product Overview
Table 97. CSL Limited Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CSL Limited Business Overview
Table 99. CSL Limited Recent Developments
Table 100. Serum Institute of India Pvt. Ltd. Basic Information
Table 101. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Overview
Table 102. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Serum Institute of India Pvt. Ltd. Business Overview
Table 104. Serum Institute of India Pvt. Ltd. Recent Developments
Table 105. Biken Basic Information
Table 106. Biken Attenuated Vaccine Product Overview
Table 107. Biken Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biken Business Overview
Table 109. Biken Recent Developments
Table 110. Green Cross Corporation Basic Information
Table 111. Green Cross Corporation Attenuated Vaccine Product Overview
Table 112. Green Cross Corporation Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Green Cross Corporation Business Overview
Table 114. Green Cross Corporation Recent Developments
Table 115. Shanghai Rongsheng Biotech Basic Information
Table 116. Shanghai Rongsheng Biotech Attenuated Vaccine Product Overview
Table 117. Shanghai Rongsheng Biotech Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Shanghai Rongsheng Biotech Business Overview
Table 119. Shanghai Rongsheng Biotech Recent Developments
Table 120. Changchun BCHT Biotechnology Co.,Ltd Basic Information
Table 121. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Overview
Table 122. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Changchun BCHT Biotechnology Co.,Ltd Business Overview
Table 124. Changchun BCHT Biotechnology Co.,Ltd Recent Developments
Table 125. Global Attenuated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Attenuated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Attenuated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Attenuated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Attenuated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Attenuated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Attenuated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Attenuated Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Attenuated Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Attenuated Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Attenuated Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Attenuated Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Attenuated Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Attenuated Vaccine Market Size by Type (M USD)
Table 4. Global Attenuated Vaccine Market Size by Application
Table 5. Attenuated Vaccine Market Size Comparison by Region (M USD)
Table 6. Global Attenuated Vaccine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Attenuated Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Attenuated Vaccine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Attenuated Vaccine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Attenuated Vaccine as of 2025)
Table 11. Global Market Attenuated Vaccine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Attenuated Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Attenuated Vaccine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Attenuated Vaccine Sales by Type (K MT)
Table 27. Global Attenuated Vaccine Market Size by Type (M USD)
Table 28. Global Attenuated Vaccine Sales (K MT) by Type (2020-2025)
Table 29. Global Attenuated Vaccine Sales Market Share by Type (2020-2025)
Table 30. Global Attenuated Vaccine Market Size (M USD) by Type (2020-2025)
Table 31. Global Attenuated Vaccine Market Share by Type (2020-2025)
Table 32. Global Attenuated Vaccine Price (USD/KG) by Type (2020-2025)
Table 33. Global Attenuated Vaccine Sales (K MT) by Application
Table 34. Global Attenuated Vaccine Market Size by Application
Table 35. Global Attenuated Vaccine Sales by Application (2020-2025) & (K MT)
Table 36. Global Attenuated Vaccine Sales Market Share by Application (2020-2025)
Table 37. Global Attenuated Vaccine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Attenuated Vaccine Market Share by Application (2020-2025)
Table 39. Global Attenuated Vaccine Sales Growth Rate by Application (2020-2025)
Table 40. Global Attenuated Vaccine Sales by Region (2020-2025) & (K MT)
Table 41. Global Attenuated Vaccine Sales Market Share by Region (2020-2025)
Table 42. Global Attenuated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Attenuated Vaccine Market Size by Region (2020-2025)
Table 44. North America Attenuated Vaccine Sales by Country (2020-2025) & (K MT)
Table 45. North America Attenuated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Attenuated Vaccine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Attenuated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Attenuated Vaccine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Attenuated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Attenuated Vaccine Sales by Country (2020-2025) & (K MT)
Table 51. South America Attenuated Vaccine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Attenuated Vaccine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Attenuated Vaccine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Attenuated Vaccine Production (K MT) by Region(2020-2025)
Table 55. Global Attenuated Vaccine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Attenuated Vaccine Revenue Market Share by Region (2020-2025)
Table 57. Global Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Attenuated Vaccine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck and Co. Basic Information
Table 63. Merck and Co. Attenuated Vaccine Product Overview
Table 64. Merck and Co. Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck and Co. Business Overview
Table 66. Merck and Co. SWOT Analysis
Table 67. Merck and Co. Recent Developments
Table 68. GlaxoSmithKline plc Basic Information
Table 69. GlaxoSmithKline plc Attenuated Vaccine Product Overview
Table 70. GlaxoSmithKline plc Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. GlaxoSmithKline plc Business Overview
Table 72. GlaxoSmithKline plc SWOT Analysis
Table 73. GlaxoSmithKline plc Recent Developments
Table 74. Pfizer Inc Basic Information
Table 75. Pfizer Inc Attenuated Vaccine Product Overview
Table 76. Pfizer Inc Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Inc Business Overview
Table 78. Pfizer Inc SWOT Analysis
Table 79. Pfizer Inc Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Attenuated Vaccine Product Overview
Table 82. Sanofi Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. Astellas Pharma Basic Information
Table 86. Astellas Pharma Attenuated Vaccine Product Overview
Table 87. Astellas Pharma Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Astellas Pharma Business Overview
Table 89. Astellas Pharma Recent Developments
Table 90. Johnson and Johnson Basic Information
Table 91. Johnson and Johnson Attenuated Vaccine Product Overview
Table 92. Johnson and Johnson Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Johnson and Johnson Business Overview
Table 94. Johnson and Johnson Recent Developments
Table 95. CSL Limited Basic Information
Table 96. CSL Limited Attenuated Vaccine Product Overview
Table 97. CSL Limited Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. CSL Limited Business Overview
Table 99. CSL Limited Recent Developments
Table 100. Serum Institute of India Pvt. Ltd. Basic Information
Table 101. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Product Overview
Table 102. Serum Institute of India Pvt. Ltd. Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Serum Institute of India Pvt. Ltd. Business Overview
Table 104. Serum Institute of India Pvt. Ltd. Recent Developments
Table 105. Biken Basic Information
Table 106. Biken Attenuated Vaccine Product Overview
Table 107. Biken Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Biken Business Overview
Table 109. Biken Recent Developments
Table 110. Green Cross Corporation Basic Information
Table 111. Green Cross Corporation Attenuated Vaccine Product Overview
Table 112. Green Cross Corporation Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Green Cross Corporation Business Overview
Table 114. Green Cross Corporation Recent Developments
Table 115. Shanghai Rongsheng Biotech Basic Information
Table 116. Shanghai Rongsheng Biotech Attenuated Vaccine Product Overview
Table 117. Shanghai Rongsheng Biotech Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Shanghai Rongsheng Biotech Business Overview
Table 119. Shanghai Rongsheng Biotech Recent Developments
Table 120. Changchun BCHT Biotechnology Co.,Ltd Basic Information
Table 121. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Product Overview
Table 122. Changchun BCHT Biotechnology Co.,Ltd Attenuated Vaccine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Changchun BCHT Biotechnology Co.,Ltd Business Overview
Table 124. Changchun BCHT Biotechnology Co.,Ltd Recent Developments
Table 125. Global Attenuated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Attenuated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Attenuated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Attenuated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Attenuated Vaccine Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Attenuated Vaccine Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Attenuated Vaccine Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Attenuated Vaccine Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Attenuated Vaccine Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Attenuated Vaccine Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Attenuated Vaccine Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Attenuated Vaccine Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Attenuated Vaccine Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Attenuated Vaccine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Attenuated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Attenuated Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Attenuated Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Attenuated Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Attenuated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Attenuated Vaccine Product Life Cycle
Figure 13. Attenuated Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Attenuated Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Attenuated Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Attenuated Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Attenuated Vaccine
Figure 19. Global Attenuated Vaccine Market PEST Analysis
Figure 20. Global Attenuated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Attenuated Vaccine Market Share by Type
Figure 27. Sales Market Share of Attenuated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Attenuated Vaccine by Type in 2025
Figure 29. Market Share of Attenuated Vaccine by Type (2020-2025)
Figure 30. Market Share of Attenuated Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Attenuated Vaccine Market Share by Application
Figure 33. Global Attenuated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Attenuated Vaccine Sales Market Share by Application in 2025
Figure 35. Global Attenuated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Attenuated Vaccine Market Share by Application in 2025
Figure 37. Global Attenuated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Attenuated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Attenuated Vaccine Market Size by Region (2020-2025)
Figure 40. North America Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Attenuated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Attenuated Vaccine Market Size by Country in 2024
Figure 45. U.S. Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Attenuated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Attenuated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Attenuated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Attenuated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Attenuated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Attenuated Vaccine Market Size by Country in 2024
Figure 55. Germany Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Attenuated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Attenuated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Attenuated Vaccine Market Size by Region in 2024
Figure 68. China Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Attenuated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Attenuated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Attenuated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Attenuated Vaccine Market Size by Country in 2024
Figure 82. Brazil Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Attenuated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Attenuated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Attenuated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Attenuated Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Attenuated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Attenuated Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Attenuated Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Attenuated Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Attenuated Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Attenuated Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Attenuated Vaccine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Attenuated Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Attenuated Vaccine Market Size (M USD), 2025-2035
Figure 5. Global Attenuated Vaccine Market Size (M USD) (2020-2035)
Figure 6. Global Attenuated Vaccine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Attenuated Vaccine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Attenuated Vaccine Product Life Cycle
Figure 13. Attenuated Vaccine Sales Share by Manufacturers in 2025
Figure 14. Global Attenuated Vaccine Revenue Share by Manufacturers in 2025
Figure 15. Attenuated Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Attenuated Vaccine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Attenuated Vaccine Revenue in 2025
Figure 18. Industry Chain Map of Attenuated Vaccine
Figure 19. Global Attenuated Vaccine Market PEST Analysis
Figure 20. Global Attenuated Vaccine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Attenuated Vaccine Market Share by Type
Figure 27. Sales Market Share of Attenuated Vaccine by Type (2020-2025)
Figure 28. Sales Market Share of Attenuated Vaccine by Type in 2025
Figure 29. Market Share of Attenuated Vaccine by Type (2020-2025)
Figure 30. Market Share of Attenuated Vaccine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Attenuated Vaccine Market Share by Application
Figure 33. Global Attenuated Vaccine Sales Market Share by Application (2020-2025)
Figure 34. Global Attenuated Vaccine Sales Market Share by Application in 2025
Figure 35. Global Attenuated Vaccine Market Share by Application (2020-2025)
Figure 36. Global Attenuated Vaccine Market Share by Application in 2025
Figure 37. Global Attenuated Vaccine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Attenuated Vaccine Sales Market Share by Region (2020-2025)
Figure 39. Global Attenuated Vaccine Market Size by Region (2020-2025)
Figure 40. North America Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Attenuated Vaccine Sales Market Share by Country in 2024
Figure 43. North America Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Attenuated Vaccine Market Size by Country in 2024
Figure 45. U.S. Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Attenuated Vaccine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Attenuated Vaccine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Attenuated Vaccine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Attenuated Vaccine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Attenuated Vaccine Sales Market Share by Country in 2024
Figure 53. Europe Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Attenuated Vaccine Market Size by Country in 2024
Figure 55. Germany Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Attenuated Vaccine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Attenuated Vaccine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Attenuated Vaccine Market Size by Region in 2024
Figure 68. China Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Attenuated Vaccine Sales and Growth Rate (K MT)
Figure 79. South America Attenuated Vaccine Sales Market Share by Country in 2024
Figure 80. South America Attenuated Vaccine Market Size and Growth Rate (M USD)
Figure 81. South America Attenuated Vaccine Market Size by Country in 2024
Figure 82. Brazil Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Attenuated Vaccine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Attenuated Vaccine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Attenuated Vaccine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Attenuated Vaccine Market Size by Region in 2024
Figure 92. Saudi Arabia Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Attenuated Vaccine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Attenuated Vaccine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Attenuated Vaccine Production Market Share by Region (2020-2025)
Figure 103. North America Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Attenuated Vaccine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Attenuated Vaccine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Attenuated Vaccine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Attenuated Vaccine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Attenuated Vaccine Market Share Forecast by Type (2026-2035)
Figure 111. Global Attenuated Vaccine Sales Forecast by Application (2026-2035)
Figure 112. Global Attenuated Vaccine Market Share Forecast by Application (2026-2035)
